NCT06272045 Early Intervention to Promote Cardiovascular Health of Mothers and Children
| NCT ID | NCT06272045 |
| Status | Recruiting |
| Phase | — |
| Sponsor | JHSPH Center for Clinical Trials |
| Condition | Cardiovascular Health |
| Study Type | INTERVENTIONAL |
| Enrollment | 6,618 participants |
| Start Date | 2024-06-19 |
| Primary Completion | 2028-03-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 6,618 participants in total. It began in 2024-06-19 with a primary completion date of 2028-03-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) is a cluster randomized clinical trial, funded by the National Heart Lung \& Blood Institute. The study is designed to test the effectiveness of home visiting intervention to promote cardiovascular health and reduce disparities in maternal and early childhood cardiovascular health. Sites, in partnership with evidence-based home visiting programs, are recruiting 6618 participants in total (i.e., 3309 mother-child dyads which includes 3309 mothers and 3309 children) from diverse community settings with a high burden of cardiovascular disease risk factors.
Eligibility Criteria
Inclusion Criteria: 1. Be currently enrolled in an evidence-based home visiting program participating in ENRICH 2. Be pregnant, with a single or multifetal gestation, at or less than 34 weeks 0 days gestation (per self-report at time of consent) 3. Be 18 years of age or older 4. Speak English or Spanish Exclusion Criteria: There are no exclusion criteria being applied in assessing eligibility for participation in ENRICH.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06272045 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Cardiovascular Health. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06272045 currently recruiting?
Yes, NCT06272045 is actively recruiting participants. Contact the research team at lburrel1@jh.edu for enrollment information.
Where is the NCT06272045 trial being conducted?
This trial is being conducted at Birmingham, United States, San Luis Obispo, United States, Aurora, United States, Chicago, United States and 5 additional locations.
Who is sponsoring the NCT06272045 clinical trial?
NCT06272045 is sponsored by JHSPH Center for Clinical Trials. The trial plans to enroll 6,618 participants.